23 329

Cited 0 times in

Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography.

Authors
Hwang, K; Park, CH; Kim, HC; Kim, H; Yoon, S; Pai, M; Kim, S
Citation
Clinical nuclear medicine, 25(10):789-795, 2000
Journal Title
Clinical nuclear medicine
ISSN
0363-97621536-0229
Abstract
PURPOSE: The authors evaluated the utility of F-18 fluorodeoxyglucose (FDG) coincidence detection (CoDe) positron emission tomography (PET) for staging, post-treatment evaluation, and follow-up assessment of patients with malignant lymphomas.



MATERIALS AND METHODS: Fifty-eight patients with histologically proved malignant lymphomas (4 Hodgkin's disease, 54 non-Hodgkin's lymphoma) underwent CoDe PET using F-18 FDG. CoDe PET was performed using a dual-head gamma camera equipped with coincidence detection circuitry. Of the 87 CoDe PET studies, 26 were performed for staging, 38 for post-treatment evaluation, and 23 for follow-up evaluation of recurrence. The entire trunk, from the cervical to the inguinal regions, or selected regions were scanned with the patient in the supine position. No attenuation correction was made and reconstruction was performed using filtered back-projection rather than iterative reconstruction. CoDe PET findings were compared with corresponding results of computed tomographic (CT) and magnetic resonance imaging (MRI), tissue biopsy, or clinical follow-up.



RESULTS: For staging, 52 sites were positive on CoDe PET or CT-MRI. CoDe PET detected 49 sites (94%), and CT-MRI showed 47 sites (90%). CoDe PET detected five more lymphomatous lesions and missed three lesions. For post-treatment evaluation, CoDe PET showed a positive predictive value of 100% and a negative predictive value of 83%, but the validated cases numbered only 11. For follow-up for recurrence, CoDe PET had a negative predictive value of 90%, but frequent false-positive findings were noted in the head and neck region as a result of underlying inflammatory changes.



CONCLUSIONS: For staging, FDG CoDe PET alone without attenuation correction is not sensitive enough to be used as an independent imaging method, especially for small abdominal lesions. However, it appears to be an accurate method for assessing residual disease and for patient follow-up.
MeSH terms
AdolescentAdultAgedChildChild, PreschoolFemaleFluorodeoxyglucose F18/*diagnostic useFollow-Up StudiesGamma CamerasHodgkin Disease/pathology/*radionuclide imagingHumansLymphoma, Non-Hodgkin/pathology/*radionuclide imagingMagnetic Resonance ImagingMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm Staging/methodsRadiopharmaceuticals/*diagnostic useTomography, Emission-Computed/*methodsTomography, X-Ray Computed
PMID
11043718
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Journal Papers > School of Medicine / Graduate School of Medicine > Nuclear Medicine & Molecular Imaging
AJOU Authors
박, 찬희김, 효철김, 현수윤, 석남
Full Text Link
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse